Whole-genome approach implicates <it>CD44 </it>in cellular resistance to carboplatin
<p>Abstract</p> <p>Carboplatin is a chemotherapeutic agent used in the management of many cancers, yet treatment is limited by resistance and toxicities. To achieve a better understanding of the genetic contribution to carboplatin resistance or toxicities, lymphoblastoid cell lines...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2009-01-01
|
| Series: | Human Genomics |
| Subjects: | |
| Online Access: | http://www.humgenomics.com/content/3/2/128 |